Table 3 Comparative analysis of baseline characteristics in preoperative non-anemic patients who had preoperative Hb level above 12.0 g/dL
Variables | Preoperative IV iron | No IV iron | p-value |
|---|---|---|---|
n = 16 (47.1%) | n = 18 (52.9%) | ||
Demographics | |||
Age (years) | 65.3 ± 9.2 | 68.9 ± 11 | 0.306 |
Gender (male, %) | 14 (87.5) | 10 (55.6) | 0.063 |
Body mass index (kg/m− 2) | 24.3 ± 2 | 23.6 ± 2.5 | 0.349 |
ASA class over III | 3 (18.8) | 2 (11.1) | 0.648 |
Diabetes mellitus | 3 (18.8) | 3 (16.7) | 1.000 |
Hypertension | 7 (43.8) | 8 (44.4) | 1.000 |
History of stroke | 0 | 2 (11.1) | 0.487 |
Use of anticoagulant | 5 (31.2) | 6 (33.3) | 1.000 |
Tumor location | |||
Pancreas | 8 (50) | 10 (55.6) | 1.000 |
Duodenum | 1 (6.2) | 0 | 0.471 |
Common bile duct | 4 (25) | 6 (33.3) | 0.715 |
Ampulla of Vater | 3 (18.8) | 1 (5.6) | 0.323 |
Tumor staging** | |||
Stage I | 8 (50) | 10 (55.6) | 1.000 |
Stage II | 4 (25) | 6 (33.3) | 0.715 |
Stage III | 4 (25) | 1 (5.6) | 0.164 |
Tumor manifestations | |||
Concomitant malignancy | 4 (25) | 2 (11.1) | 0.387 |